A new scoring system to predict the success of single-dose methotrexate therapy in ectopic pregnancy
Open Access
- 1 January 2025
- journal article
- Published by FapUNIFESP (SciELO) in Revista da Associação Médica Brasileira
- Vol. 71 (9) , e20250639
Abstract
SUMMARY OBJECTIVE: Methotrexate remains the most commonly used agent for the medical management of ectopic pregnancy. The aim of this study was to develop a novel scoring system to predict the efficacy of single-dose methotrexate treatment in ectopic pregnancy. METHODS: In this retrospective study, information on patients diagnosed with ectopic pregnancy between January 2012 and December 2023 was obtained from the hospital information system. Notably, 156 patients received a single dose of methotrexate for ectopic pregnancy treatment and met the study criteria. Almost 117 of those who were successful in single-dose methotrexate treatment constituted the successful methotrexate treatment group. The other 39 cases who failed single-dose methotrexate treatment constituted the failed methotrexate treatment group. A new scoring system was developed based on six parameters, including serum human chorionic gonadotropin level, gestational week, and ultrasound findings. RESULTS: According to the scoring system, the total score was significantly higher in the group in which methotrexate treatment failed compared to the group with successful treatment (4 points versus 2 points, respectively, p<0.001). In receiver operating characteristic analysis, the optimal cut-off value for the scoring system was determined as 2.5, with 92% sensitivity and 78% specificity (AUC=0.804, 95%CI 0.731–0.877). The overall success rate of single-dose methotrexate treatment was 75%. However, when only patients with a score below the cut-off value of 2.5 were considered, the success rate of single-dose methotrexate treatment in ectopic pregnancy increased to 90.5%. CONCLUSION: This new scoring system significantly enhances the ability to predict outcomes of methotrexate therapy, allowing for faster decision-making regarding surgical intervention.Keywords
This publication has 11 references indexed in Scilit:
- The predictors of successful methotrexate treatment of tubal ectopic pregnancyJournal of Obstetrics and Gynaecology, 2024
- Can failure be predicted in methotrexate treatment with the modified parameter?Archives of Gynecology and Obstetrics, 2024
- Evaluation of a scoring system to predict treatment success with single-dose methotrexate in ectopic pregnancyArchives of Gynecology and Obstetrics, 2024
- Evaluation of the parameters in predicting single‐dose methotrexate therapy success for ectopic pregnancyJournal of Obstetrics and Gynaecology Research, 2024
- A 10-Year Review of Methotrexate Treatment for Ectopic Pregnancy in a Malaysian Tertiary Referral HospitalCureus, 2022
- Ectopic pregnancy: a resident’s guide to imaging findings and diagnostic pitfallsEmergency Radiology, 2021
- ACOG Practice Bulletin No. 193: Tubal Ectopic PregnancyObstetrics & Gynecology, 2018
- A new predictive scoring system including shock index for unruptured tubal pregnancy patientsEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2006
- The medical management of ectopic pregnancy: a meta-analysis comparing “single dose” and “multidose” regimensObstetrics & Gynecology, 2003
- Predictive score for the systemic treatment of unruptured ectopic pregnancy with a single dose of methotrexateInternational Journal of Gynecology & Obstetrics, 1999